Fulgent Genetics vs RadNet
FLGT and RDNT side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FLGT and RDNT compare
RadNet is the larger company, worth 8.7 times as much as Fulgent Genetics ($6.1B against $707M).
RadNet grew revenue faster over the last twelve months (21.1% versus 4.7% for Fulgent Genetics).
RadNet keeps more of each dollar of sales as profit, with a net margin of −0.94% compared with −27.5% at Fulgent Genetics.
Fulgent Genetics scores higher on the StockData Score (8 against 7 for RadNet), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FLGT | RDNT |
|---|---|---|
| Size and price | ||
| Market cap | $707M | $6.1B |
| Share price | $25.70 | $78.08 |
| Change, 1 year | −5.4% | −3.4% |
| Change, 5 years | −72.7% | 176% |
| Beta (5Y) | 0.90 | 1.16 |
| Employees | 1,300 | 76 |
| StockData Score | ||
| Total score | 8 (better) | 7 |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 4 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.1× (better) | 2.6× |
| P/B | 0.7× (better) | 5.5× |
| EV/EBITDA | – | 27.9× |
| FCF yield | −0.20% | – |
| Fair value | $50.48 | $55.32 |
| Margin of safety | 49.1% (better) | −41.1% |
| Growth | ||
| Revenue growth (TTM) | 4.7% | 21.1% (better) |
| Revenue growth, 5Y average | −5.2% | 13.7% (better) |
| Profitability | ||
| Gross margin | 33.8% | – |
| Operating margin | −39.2% | 3.1% (better) |
| Net margin | −27.5% | −0.94% (better) |
| FCF margin | −0.42% | – |
| Return on equity | −8.6% | −2.1% (better) |
| Return on invested capital | −12.0% | 2.8% (better) |
| Financial health | ||
| Debt / equity | 0.00 (better) | 1.18 |
| Net debt / EBITDA | – | 2.28 |
| Interest coverage | −1307.9× | 1.0× (better) |
| Current ratio | 5.34 (better) | 1.49 |
| Altman Z-score | 5.36 (better) | 1.97 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | 9.1% | – |
| Shareholder yield | 9.1% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 57.0% | 104% |
| Held by insiders | 39.5% | 4.6% |
| Insider net buying, 12 months | −$286K (better) | −$8.4M |
| Short interest, % of float | 12.1% | 11.8% |
Go deeper
- FLGT stock overview
- FLGT income statement
- FLGT valuation and score
- RDNT stock overview
- RDNT income statement
- RDNT valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.